Using chlorfenapyr and imidacloprid nanocapsule against Sphenophorus venatus larvae
Chlorfenapyr and imidacloprid nanocapsules were used against the sixth and third instar larvae of S. venatus (Table 1, Fig. 3 and Fig. 4). The larvae used in control (treated with water) were not affected in all treatments.
Efficacy of chlorfenapyr nanocapsule against the third instar larvae of S. venatus
Results in Table (1) and Fig. (3) show that the third instar larvae of S. venatus were affected by chlorfenapyr nanocapsule. The percentages of mortality were 88.3, 78.3 and 61.7% for the first, second, and third concentrations, respectively. The LC50 was 9.1 ppm.
Efficacy of chlorfenapyr nanocapsule against the sixth instar larvae of S. venatus
As mentioned in Table (1) and Fig. (4) the percentages of mortality to the sixth instar larvae of S. venatus which caused by chlorfenapyr nanocapsule were 85, 65 and 40% for the first, second, and third concentrations, respectively. The LC50 of chlorfenapyr nanocapsule for the sixth instar larvae of S. venatus was 11.8 ppm. The statistical analysis shows that there is no significant difference between the efficacy of chlorfenapyr nanocapsule against the sixth and third instar larvae of S. venatus with the first concentration. While there are significant differences between the second and third concentrations.
The results showed that the third instar larvae of S. venatus were more affected by chlorfenapyr nanocapsule than the sixth instar. The LC50s were 9.1 and 11.8 ppm for the third-instar and sixth-instar larvae, respectively. This means that the third instar larvae were more susceptible to chlorfenapyr nanocapsule than the sixth instar larvae (Fig. 5).
Efficacy of imidacloprid nanocapsule against the third instar larvae of S. venatus
The percentages of mortality were increased sharply with all tested concentrations of imidacloprid. The percentages of mortality were 96.7, 80 and 60% with the first, second and third concentrations, respectively. So, the LC50 was 8.8 ppm (Table 1 and Fig 6).
Efficacy of imidacloprid nanocapsule against the sixth instar larvae of S. venatus
The percentages of mortality were 95, 81.7 and 53.3% for the first, second and third concentrations, respectively. The LC50 was 8.8 ppm (Table 1). The obtained results showed that there is no difference between the efficacy of imidacloprid against the third and sixth instar larvae of S. venatus especially with the first and second concentrations (the highest concentrations). While there is a little difference with the third concentration (Fig. 7).
Data showed that the third instar larvae of S. venatus were affected by imidacloprid with the third concentration compared with the sixth instar larvae (60 and 53.3%, respectively) (Fig. 8). The less significant difference (LSD) was 7.4 with the third concentration compared with 3.3 and 3.3 with the first and second concentrations (Table 1). The LC50,s were 8.8 ppm with the third instar larvae compared with 10.3 ppm with the sixth instar larvae.
To throw some light on the efficacy of both chlorfenapyr and imidacloprid nanocapsule against the third and sixth instar larvae of S. venatus; data showed that imidacloprid was more effective than chlorfenapyr with both the third and sixth instar larvae of S. venatus. For the first concentration the percentage of mortalities caused by imidacloprid were 96.7 and 95% against the third and sixth instar larvae, respectively, compared with 88.3 and 85% in chlorfenapyr treatment. The same results were found with the second and third concentrations (Table 1).
These results were consistent with Heller et al. (2008). The authors found that the percentage of mortalities caused by imidacloprid against S. venatus larvae ranged between 62.1% and 79.4%. Reynolds and Brandenbur (2015) found that the percentage of mortality caused by imidacloprid against S. venatus larvae wasn't exceeded 33.6% with a concentration of 0.77 Ib ai/ha. In this work, one–tenth of this concentration caroused 96.6 %. This means that imidacloprid nanoformulation was more effective than the normal formulation. Sabry et al. (2021) found that nanoparticles of imidacloprid were very effective against Spodoptera littoralis larvae compared with the normal formulation. Sabry and Hussein (2021) found also the nanoformulation of both imidacloprid and chlorfenapyr was more effective against Monacha cartusiana than the normal formulations. Memarizadeh et al. 2014. Used imidacloprid nanocapsule against Glyphodes pyloalis. The results showed that the nanocapsule of imidacloprid was more effective against this pest and also safer in the environment than the normal formulation.
Using of chlorfenapyr and imidacloprid nanocapsule against Phyllophaga crinita larvae
Table (2) shows that the efficacy of both chlorfenapyr and imidacloprid against the first and third instar larvae of P. crinita
Efficacy of chlorfenapyr nanocapsule against the first instar larvae of P. crinita
Three concentrations of chlorfenapyr nanocapsule were used. The first concentration of chlorfenapyr caused the highest mortality percentage followed by the second and the third concentrations. The percent of mortalities were 86.7, 65 and 41.7% for the first, second and third concentrations, respectively (Table 2 and Fig. 9). The LC50 was 11.6 ppm.
Efficacy of chlorfenapyr nanocapsule against the third instar larvae of P. crinita
The obtained data in Table (2) and Fig. (10) show that the percent of mortality caused by chlorfenapyr nanocapsule was 75, 48.3, and 31.7% for the first, second, and third concentrations, respectively. The LC50 was 17.2.
The obtained data showed that the third instar larvae of P. crinita were more tolerant to chlorfenapyr nanocapsule than the first instar. The LC50 were 17.2 and 11.6 for the third and first instar larvae, respectively (Table 2 and Fig. 9). The statistical analysis showed that there were significant differences among all tested concentrations of chlorfenapyr nanocapsule against the third and first instar larvae. The less significant difference (LSD 5%) values were 6.7, 6.7, and 4.7 for the first, second and third concentrations, respectively (Fig. 11).
Efficacy of imidacloprid nanocapsule against the first instar larvae of P. crinita
As clear in Table (2) and Fig. (12) imidacloprid was very effective against the first instar larvae of P. crinita. The percentages of mortality were 95, 80 and 60% for the first, second, and third concentrations, respectively. The LC50 was 8.7 ppm.
Efficacy of imidacloprid nanocapsule against the third instar larvae of P. crinita
The third instar larvae of P. crinita was affected by imidacloprid. The percent of mortality with the first concentration (the highest concentration) was 91.7% (Table 2 and Fig. 13). The percentages of mortality for the second and third concentrations were 71.7 and 51.7, respectively. The LC50 was 11.2 ppm. The obtained data found that the first instar larvae of P. crinita were more affected than the third instar. This may be due to the size of the larvae. The third instar was bigger than the first instar. So, the third instar was more tolerant to imidacloprid than the first instar (Fig. 14). The LC50,s were 8.7 and 11.2 ppm for the first and third instar larvae, respectively.
The statistical analysis showed that there was a significant difference between the efficacy of chlorfenapyr nanocapsule against the first and third instar larvae of P. crinita. While there was no significant difference with the imidacloprid
These results were consistent with Niemczyk and Shetlar (2000). The author used imidacloprid against the earlier-hatching black turf-grass ataenius, Ataenius spretulus (which infests the golf courses). They found that imidacloprid is very effective against this pest because it has a long residual effect. Koppenhofer et al. (2008) used imidacloprid against the second and third-instar larvae of P. crinita in cranberry fields.